Related Experiment Video
Updated: Oct 26, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells
Ning Zhang1, Xiaohui Hua2, Huailu Tu1
1Department of Environmental Medicine, New York University Grossman School of Medicine, 341 East 25th Street, New York, NY, 10010, USA.
Abstract:
Epithelial mesenchymal transition (EMT) is highly correlated with metastasis during cancer development. Although previous studies have revealed that ISO is able to inhibit cancer cell invasion and stem-cell properties, little is known about the effects of ISO on EMT markers. The present study explores the potential regulation of ISO on EMT, leading to the inhibition of migration and invasion of bladder cancer cells. We found that ISO inhibited Vimentin, one of the EMT markers, in the invasive bladder cancer cell lines U5637 and T24T. ISO reduced Vimentin protein level by increasing the expression of METTL14. On the other hand, ISO upregulated the METTL14 mRNA by activating the transcription factor FOXO3a. The results demonstrate that ISO inhibits invasion by affecting the EMT marker and offer a novel insight into understanding the upregulation of METTL14 by ISO.
Insights
Isoflavone (ISO) inhibits bladder cancer cell invasion by reducing Vimentin, a key marker of epithelial mesenchymal transition (EMT). This occurs through upregulation of METTL14 via the FOXO3a pathway, offering new therapeutic insights.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Epithelial mesenchymal transition (EMT) is crucial for cancer metastasis.
- Isoflavone (ISO) is known to inhibit cancer cell invasion and stem-cell properties.
- The effect of ISO on EMT markers remains largely unexplored.
Purpose of the Study:
- To investigate the regulatory role of ISO on EMT in bladder cancer.
- To determine if ISO affects EMT markers, leading to reduced migration and invasion.
- To elucidate the molecular mechanisms underlying ISO's effects on bladder cancer cells.
Main Methods:
- Utilized invasive bladder cancer cell lines (U5637 and T24T).
- Assessed the protein and mRNA levels of EMT markers, specifically Vimentin.
- Investigated the expression of METTL14 and the transcription factor FOXO3a.
- Analyzed the regulatory pathways connecting ISO, FOXO3a, METTL14, and Vimentin.
Main Results:
- ISO significantly inhibited Vimentin protein levels in bladder cancer cells.
- ISO treatment led to increased expression of METTL14.
- ISO upregulated METTL14 mRNA by activating the transcription factor FOXO3a.
- These molecular changes correlated with reduced cancer cell invasion and migration.
Conclusions:
- ISO effectively inhibits bladder cancer cell invasion by modulating EMT markers.
- ISO upregulates METTL14 expression through the FOXO3a pathway, impacting Vimentin levels.
- This study provides novel insights into the anti-metastatic potential of ISO via EMT regulation.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Regulation of Angiogenesis and Blood Supply
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

